Interstitial lung disease in polymyositis and dermatomyositis.

Medicine and Dentistry

• Cyclophosphamide 50%
• Deterioration 25%
• Disease Course 25%
• Histopathology 25%
• Idiopathic Interstitial Pneumonia 25%
• Idiopathic Pulmonary Fibrosis 25%
• Immunosuppressive Treatment 50%
• Interstitial Lung Disease 100%
• Long Term Survival 25%
• Monotherapy 25%
• Pulse Rate 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Deterioration 25%
• Disease Course 25%
• Fibrosing Alveolitis 25%
• Immunosuppressive Agent 25%
• Interstitial Pneumonia 50%
• Long Term Survival 25%
• Monotherapy 25%
• Skin Disease 25%